Volume 108, Issue 1 pp. 17-23
Full Access

Ornithine decarboxylase induction in psoralen-treated mouse epidermis used as a test of UV-A sunscreen potency

J. FOLSO

J. FOLSO

Department of Dermatology, Naval Regional Medical Centre, San Diego

Search for more papers by this author
R.W. GANGE

Corresponding Author

R.W. GANGE

Division of Dermatology, University of California, School of Medicine, San Diego, U.S.A.

Dr R.W. Gange, Department of Dermatology, Photomedicine Research Unit, Wellman Laboratories, Massachusetts General Hospital, Boston, Massachusetts 02114, U.S.A.Search for more papers by this author
I.R. MENDELSON

I.R. MENDELSON

Division of Dermatology, University of California, School of Medicine, San Diego, U.S.A.

Search for more papers by this author
First published: January 1983
Citations: 11

SUMMARY

Inhibition by sunscreens of UV-A-induced epidermal ornithine decarboxylase (ODC) activity in 8-methoxypsoralen-treated mice was used to examine the UV-A sunscreen activity of two commercial preparations, Uval® (para-aminobenzoic acid) and PreSun® (a benzophenone derivative). Both gave significant protection against UV-A doses of up to 3 J/cm2 and Uval® was more effective that PreSun® in the UV-A range. At intermediate doses (5–15 J/cm2) neither Uval® nor PreSun® significantly altered the ODC response to UV-A. At doses of 20–40 J/cm2 UV-A, control and PreSun®-treated animals showed a decline in ODC activity which histological studies suggested was due to severe epidermal damage. This decline in ODC activity and severe epidermal damage was not seen in Uval® -treated animals. Topical zinc oxide was highly effective in preventing induction of ODC by UV-A irradiation at doses up to 40 J/cm2, and was significantly more effective than either PreSun® or Uval®.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.